New nerve block could slash opioid use after heart surgery
NCT ID NCT07412522
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a specific nerve block, called the serratus posterior superior intercostal plane block, can reduce pain and opioid use after minimally invasive heart bypass surgery. Sixty adults undergoing this surgery will be randomly assigned to receive either the nerve block with bupivacaine or standard anesthesia alone. The main goal is to see if the block improves overall recovery quality and reduces the need for painkillers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If effective, this nerve block could become a standard way to manage pain after heart surgery, reducing reliance on opioids and speeding recovery.
- What could go wrong
- This is a small, early-stage study with only 60 participants. The block may not provide significant pain relief, and there are risks like bleeding or infection at the injection site.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kosuyolu High Specialization Training and Research Hospital
RECRUITINGIstanbul, 34870, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Can patients safely dispense their own pain medicine after surgery?
- Can a VR headset calm nerves before surgery?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?